Elvie’s Early-Stage Disease Detection Technology

Elvie’s AlertTechServices LLC  (AlertTech) has developed proprietary screening technology that will revolutionize healthcare by allowing physicians to cost-effectively and noninvasively screen for several life threatening and prevalent diseases with a simple breath test.  The technology can be used as a simple alternative to standard invasive blood and urine analysis, endoscopy or expensive imaging techniques such as CT scans.

Benefits over conventional urine, blood or radiography include:

  • Noninvasive Nature
  • Early Stage Disease Detection
  • Real-Time Results
  • Reduced Costs as Compared to Traditional Tests

Early Stage Screening For:

  • Asthma – diagnose, monitor and manage asthma.
  • Bacterial/Viral -  screen to reduce and target antibiotics prescriptions.
  • Cancer Screening (lung, breast, bowel and prostate) – early stage screening system that flags several types of cancer before tumors become visible in x-rays.  Early detection is essential for positive outcomes.
  • Diabetes – diagnose and monitor diabetes as a noninvasive alternative of the currently used blood-based tests.
  • Tuberculosis (TB) – real-time alternative to skin or blood-based tests.
  • Multiple Sclerosis (MS) – fast, inexpensive and noninvasive test. MS is the most common neurological disease in young adults.
  • Drug Screening – Breathalyzer type test for drug screening.


Leave a Reply